| Literature DB >> 33294181 |
Michael Tendean1, Toar D B Mambu1, Ferdinand Tjandra1, Jimmy Panelewen1.
Abstract
INTRODUCTION: Several modalities are used to improve the outcome of liver resection surgery. Laser-based surgery may become promising option; therefore we aim to report our experience regarding the efficacy and safety of Thulium-Doped Fiber Laser (TDFL) 1940 nm in liver parenchyma resection.Entities:
Keywords: Laser-based surgery; Liver resection; Liver surgery; Thulium-doped fiber laser
Year: 2020 PMID: 33294181 PMCID: PMC7691678 DOI: 10.1016/j.amsu.2020.11.039
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1A. The Multipulse TM +1470 nm emitting the Thulium laser at 1940 nm and Raman laser at 1470 nm, B. The TDFL being used by the author as an energy device to perform liver parenchyma resection.
Patients characteristics.
| Characteristics | Total (n = 17) | Multipulse TM + 1470 (TDFL) (n = 8) |
|---|---|---|
| Age mean ± standard deviation, years old | 56.5 (2.23) | 57.38 (3.74) |
| Male, n (%) | 11 (64.71) | 6 (75) |
| Cause of disease, n (%) | ||
| Metastatic liver tumor | 5 (29.4) | 4 (50) |
| Hepatocellular carcinoma | 7 (41.2) | 2 (25) |
| Cholangiocarcinoma | 2 (11.8) | 0 (0) |
| Other benign etiology or Polycystic liver disease | 3 (17.7) | 2 (25) |
| Background liver (n) | ||
| Normal | 14 (82.4) | 8 (100) |
| Cirrhosis or chronic hepatitis | 3 (17.7) | 0 (0) |
| Tumor | ||
| Size (cm) | ||
| <5 | 1 (0.06) | 0 (0) |
| ≥5 | 16 (94.1) | 8 (100) |
| Number | ||
| Single | 12 (70.6) | 7 (87.5) |
| Multiple | 5 (29.4) | 1 (12.5) |
| Type of hepatectomy, n (%) | ||
| Major | ||
| Extended hemihepatectomy | 3 (17.7) | 0 (0) |
| Hemihepatectomy | 4 (23.5) | 1 (12.5) |
| Minor | ||
| Segmentectomy | 8 (47.1) | 5 (62.5) |
| Limited resection | 2 (11.8) | 2 (25) |
| Number of resections, n (%) | ||
| Single | 12 (70.6) | 7 (87.5) |
| Multiple | 5 (29.4) | 1 (12.5) |
| Combined Resection and Reconstruction, n (%) | ||
| Colorectal resection | 2 (11.8) | 2 (25) |
| Hepatic vein resection | 2 (11.8) | 1 (12.5) |
Fig. 2A. The TDFL cutting function in Systematic Extended Right Posterior Sectionectomy (SERPS), the minuscule tip of laser fiber (*) able to cut the parenchyma with close proximity to major vascular and biliary structures, B. The coagulation function (**) for hemostasis from the raw liver surface, C. The liver parenchyma transected plane (***) by TDFL showed excellent hemostasis and no bile leakage.
Surgical outcomes in liver parenchyma transection using Multipulse TM+1470 (TDFL).
| Outcomes | Multipulse TM + 1470 (TDFL) (n = 8) |
|---|---|
| Blood loss (ml) | |
| Total | 628.13 ± 141.31 |
| During transection | 294.63 ± 94.81 |
| Liver transection | |
| Time (min) | 66.13 ± 11.66 |
| Area (cm2) | 106.57 ± 27.70 |
| Speed (cm2/min) | 1.52 ± 0.27 |
| Pringle maneuver time (minutes) | 8.75 ± 3.87 |
| Perioperative blood transfusion (units) | 1.13 ± 0.35 |
All values are expressed as mean ± standard deviation.
Surgical complications in liver parenchyma transection using Multipulse TM+1470 (TDFL).
| Complications | Multipulse TM + 1470 (TDFL) (n = 8) |
|---|---|
| Postoperative hospital stays (day) | 8.5 ± 0.96 |
| Mortality, n (%) | 0 (0) |
| Morbidity, n (%) | 2 (25) |
| Bile leak | 0 (0) |
| Ascites or pleural effusion | 2 (25) |
| Ileus | 0 (0) |
| Catheter infection | 0 (0) |
| Lung edema | 0 (0) |
| Adrenal hemorrhage | 0 (0) |
Post Hepatectomy Liver Failure criteria based on the increase of total bilirubin and INR on postoperative day 5 in Multipulse TM+1470 (TDFL) group.
| No | Patient | Age | Diagnosis | Type of resection | Total bilirubin (mg/dl)/INR postoperative day 1 | Total bilirubin (mg/dl)/INR postoperative day 3 | Total bilirubin (mg/dl)/INR postoperative day 5 | PHLF by ISGLS |
|---|---|---|---|---|---|---|---|---|
| 1 | ♂ | 66 | HCC segment 6 | Anatomical segmentectomy 6 | 1.18/1.40 | 2.60/1.39 | 1.30/1.32 | None |
| 2 | ♂ | 61 | MCRC segment 7-8 | Non-anatomical metastasectomy segment 7-8 | 1.41/1.35 | 0.70/2.29 | 0.84/1.40 | None |
| 3 | ♂ | 51 | GIST liver metastasis segment 6-7 | SERPS (Segment 6–7 + RHV) | 0.88/3.19 | 0.68/1.99 | 0.56/1.54 | None |
| 4 | ♂ | 70 | MCRC segment 3,7 | Non-anatomical metastasectomy segment 3,7 | 0.28/1.29 | 0.78/1.49 | 0.45/0.95 | None |
| 5 | ♀ | 66 | HCC segment 5-6 | Non-anatomical liver resection Segmentectomy 5-6 | 1.02/1.33 | 1.39/1.30 | 0.93/1.25 | None |
| 6 | ♂ | 55 | HCC segment 5 | Anatomical segmentectomy 5 | 3.66/1.47 | 2.45/1.41 | 1.54/1.34 | None |
| 7 | ♂ | 44 | MCRC segment 7-8 | Bisegmentectomy 7-8 | 1.26/1.46 | 1.29/1.27 | 0.62/1.34 | None |
| 8 | ♀ | 46 | Policystic liver disease | Right Hepatectomy | 0.89/1.63 | 1.06/1.24 | 0.64/1.07 | None |
*HCC = Hepatocellular Carcinoma, MCRC = Metastase Colorectal Cancer, GIST = Gastro Instestinal Stromal Tumor, SERPS = Systematic Extended Right Posterior Sectionectomy, PHLF = Post Hepatectomy Liver Failure.